ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.320
-0.020 (-1.49%)
Jun 9, 2026, 4:00 PM EDT - Market closed
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $33.36 million as of June 9, 2026. Its market cap has increased by 64.32% in one year.
Market Cap
33.36M
Enterprise Value
35.88M
1-Year Change
64.32%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $33.36M, a decrease of -58.04%. That is a compound annual growth rate of -16.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 34.80M | -32.82% |
| Dec 31, 2025 | 51.80M | 572.73% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
| Aug 3, 2021 | 79.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Plus Therapeutics | 37.12M |
| Grace Therapeutics | 35.59M |
| Actinium Pharmaceuticals | 33.67M |
| INmune Bio | 33.50M |
| Boundless Bio | 31.83M |
| NanoViricides | 31.44M |
| Apollomics | 30.74M |
| Aligos Therapeutics | 30.38M |